Aladdin Scientific
Stamulumab (anti-Myostatin) (C007B-554067)
Stamulumab (anti-Myostatin) binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab (anti-Myostatin) leads to muscle fiber hypertrophy and not hyperplasia in SCID mice.
Description
Stamulumab (anti-Myostatin) binds to myostatin and neutralizes its activity by preventing binding to its endogenous high-affinity receptor ActRIIB. Stamulumab (anti-Myostatin) leads to muscle fiber hypertrophy and not hyperplasia in SCID mice. Stamulumab (anti-Myostatin) has the potential for Becker muscular dystrophy (BMD), facioscapulohumeral dystrophy (FSHD), and limb-girdle muscular dystrophy (LGMD) research.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB191951-SCI_bc48a8825cd62a3818c4411d894627ef.pdf
Specifications
- UPC:
- 51183709
- Condition:
- New
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- Ab191951-10mg
- CAS:
- 705287-60-1
- Product Size:
- 10mg
-
Fast shipping — 3-day lead time
-
Guaranteed quality & reliable delivery
-
Shipping Lead-Time: 4-8 weeks
